MedTrace Logo

Alternative Surveillance Program for Patients With High Risk Group of HCC

NCT05657249 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 199

Last updated 2025-05-15

No results posted yet for this study

Summary

In a high-risk group, ultrasonography at 6-month intervals and short-protocol magnetic resonance imaging at 1-year intervals were performed. sensitivity, specificity, positive and negative predictive values for very early stage HCC are compared between conventional (biannual US) and alternative surveillance test are compared

Conditions

Interventions

DIAGNOSTIC_TEST

Non-contrast focused MRI

non-contrast liver MRI focusing on HCC surveillance in a short scan time.

Sponsors & Collaborators

  • Severance Hospital

    collaborator OTHER

  • The Catholic University of Korea

    collaborator OTHER

  • Korea University Guro Hospital

    collaborator OTHER

  • Seoul National University Hospital

    lead OTHER

Principal Investigators

  • Jeong Hee Yoon, MD · Seoul National University Hospital

Study Design

Allocation
NA
Purpose
SCREENING
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
40 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-01-06
Primary Completion
2026-02-28
Completion
2026-12-31

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05657249 on ClinicalTrials.gov